59 related articles for article (PubMed ID: 15134913)
1. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.
Ścibior A; Pietrzyk Ł; Plewa Z; Skiba A
J Trace Elem Med Biol; 2020 Sep; 61():126508. PubMed ID: 32305626
[TBL] [Abstract][Full Text] [Related]
2. Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes.
Willsky GR; Chi LH; Godzala M; Kostyniak PJ; Smee JJ; Trujillo AM; Alfano JA; Ding W; Hu Z; Crans DC
Coord Chem Rev; 2011 Oct; 255(19-20):2258-2269. PubMed ID: 23049138
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic Bis-Maltolato-OxoVanadium(IV): conversion of inactive trans- to bioactive cis-BMOV for possible binding to target PTP-1B.
Scior T; Mack HG; García JA; Koch W
Drug Des Devel Ther; 2009 Feb; 2():221-31. PubMed ID: 19920909
[TBL] [Abstract][Full Text] [Related]
4. Novel vanadyl complexes synthesis, characterization and interactions with bovine serum albumin-effects on STZ- diabetes rats.
Shaik A; Kondaparthy V; Begum A; Husain A; Chinnagalla T
Biometals; 2024 Apr; 37(2):357-369. PubMed ID: 37945804
[TBL] [Abstract][Full Text] [Related]
5. A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats.
Lopes MS; Baptistella GB; Nunes GG; Ferreira MV; Cunha JM; Oliveira KM; Acco A; Lopes MLC; Couto Alves A; Valdameri G; Moure VR; Picheth G; Manica GCM; Rego FGM
Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675446
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of an amantadine-based novel Schiff base and its transition metal complexes as potential ALP, α-amylase, and α-glucosidase inhibitors.
Ajaz A; Shaheen MA; Ahmed M; Munawar KS; Siddique AB; Karim A; Ahmad N; Rehman MFU
RSC Adv; 2023 Jan; 13(5):2756-2767. PubMed ID: 36756442
[TBL] [Abstract][Full Text] [Related]
7. Association of urinary metal profiles with altered glucose levels and diabetes risk: a population-based study in China.
Feng W; Cui X; Liu B; Liu C; Xiao Y; Lu W; Guo H; He M; Zhang X; Yuan J; Chen W; Wu T
PLoS One; 2015; 10(4):e0123742. PubMed ID: 25874871
[TBL] [Abstract][Full Text] [Related]
8. Dieth-yl(μ3-2-methyl-4-oxo-4H-pyran-3-olato-κ(4) O (3),O (4):O (3):O (3))tris-(μ2-2-methyl-4-oxo-4H-pyran-3-olato-κ(3) O (3),O (4):O (3))trizinc toluene disolvate.
Petrus R; Petrus J; Paszek K; Sobota P
Acta Crystallogr Sect E Struct Rep Online; 2013 May; 69(Pt 5):m281-2. PubMed ID: 23723783
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Characterization, and Antibacterial Studies of Pd(II) and Pt(II) Complexes of Some Diaminopyrimidine Derivatives.
Ajibade PA; Idemudia OG
Bioinorg Chem Appl; 2013; 2013():549549. PubMed ID: 23573071
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a versatile organometallic pro-drug (CORM) for experimental CO based therapeutics.
Seixas JD; Mukhopadhyay A; Santos-Silva T; Otterbein LE; Gallo DJ; Rodrigues SS; Guerreiro BH; Gonçalves AM; Penacho N; Marques AR; Coelho AC; Reis PM; Romão MJ; Romão CC
Dalton Trans; 2013 May; 42(17):5985-98. PubMed ID: 23223860
[TBL] [Abstract][Full Text] [Related]
11. Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B.
Scior T; Guevara-García JA; Melendez FJ; Abdallah HH; Do QT; Bernard P
Drug Des Devel Ther; 2010 Sep; 4():231-42. PubMed ID: 20957214
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Solution and Solid State Structure of Titanium-Maltol Complex.
Lamboy JL; Pasquale A; Rheingold AL; Meléndez E
Inorganica Chim Acta; 2007 Apr; 360(6):2115-2120. PubMed ID: 18425211
[TBL] [Abstract][Full Text] [Related]
13. Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes.
Kim YS; He Z; Hsieh WY; Liu S
Bioconjug Chem; 2007; 18(3):929-36. PubMed ID: 17352455
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
Yuen VG; Orvig C; McNeill JH
Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
[TBL] [Abstract][Full Text] [Related]
17. The influence of a new vanadium compound, bis(2,2'-bipyridine)oxovanadium(IV) sulphate on liver golgi complexes from control and streptozotocin-diabetic rats.
Kordowiak AM; Dabroś W; Kajda B
Horm Metab Res; 2002 Oct; 34(10):556-60. PubMed ID: 12439783
[TBL] [Abstract][Full Text] [Related]
18. Vanadium treatment of type 2 diabetes: a view to the future.
Thompson KH; Lichter J; LeBel C; Scaife MC; McNeill JH; Orvig C
J Inorg Biochem; 2009 Apr; 103(4):554-8. PubMed ID: 19162329
[TBL] [Abstract][Full Text] [Related]
19. Vanadium compounds as insulin mimics.
Orvig C; Thompson KH; Battell M; McNeill JH
Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
